Inscinstech is a global innovator in automated bioprocess and analytical systems, delivering solutions that accelerate biologics, gene therapy, and RNA-based drug development.
The company’s technology portfolio covers the entire workflow — from upstream culture (bioreactors) to downstream purification (FPLC, TFF) and formulation (LNP assembly, oligonucleotide synthesis).
Each system integrates intelligent automation, modular hardware, and data-driven software to ensure reproducibility, scalability, and regulatory compliance (GLP / GMP / 21 CFR Part 11).
Designed for both R&D and pilot-scale GMP environments, Inscinstech instruments empower scientists to transition seamlessly from bench to process scale.